FDA

Health Helen Branswell and Matthew Herper

FDA approves updated Covid vaccines

Health Lev Facher

ALS advocates say criticism of new drugs misses bigger picture

Politics Rachel Cohrs

STAT Plus: House committees strike deal on health transparency, PBM reform package

D.C. Diagnosis Sarah Owermohle

Setting the September calendar in health care

Pharmalot Ed Silverman

STAT Plus: FDA delays enforcement of a pharmaceutical supply chain law to stop counterfeit drugs

Pharmalot Allison DeAngelis

STAT Plus: Pharmalittle: This fall’s COVID booster rollout; approval for Pfizer’s RSV vaccine

Health Helen Branswell

U.S. health officials lay out plans to cope with respiratory virus season

D.C. Diagnosis Rachel Cohrs

STAT Plus: Abortion policy in the spotlight, DeSantis’ importation showdown, and new price hike analysis

Health Tech Lizzy Lawrence

STAT Plus: FDA panel votes against high blood pressure device from Medtronic, but lends support to ReCor Medical’s

Health Tech Lizzy Lawrence

STAT Plus: FDA greenlights medical device to combat bladder issues

Health Tech Lizzy Lawrence

STAT Plus: FDA advisory panel to debate contentious data on Medtronic’s high blood pressure device

Health Helen Branswell

FDA approves Pfizer’s RSV vaccine designed to protect newborns by immunizing parent

Health Nicholas Florko

Kellogg’s is going to war over Mexico’s nutrition label rules. A similar fight is coming to the U.S.

Biotech Andrew Joseph and Damian Garde

STAT Plus: FDA approves first treatment for ultra-rare bone disease

Health Tech Lizzy Lawrence

STAT Plus: The latest recall of Philips ventilators reveals one death, two injuries

Pharmalot Ed Silverman

STAT Plus: In a rare move, FDA threatens to fine a company for failing to report clinical trial results

Pharmalot Ed Silverman

STAT Plus: FDA warns AstraZeneca over misleading promotional materials for a COPD drug

Health Nicholas Florko

Patient advocates warn FDA proposal on salt intake could do fatal harm to people with kidney disease

First Opinion Devabhaktuni Srikrishna

Home blood pressure machines are often wrong. The FDA must speak up

Biotech Andrew Joseph and Damian Garde

STAT Plus: In the case of a devastating disease, the FDA weighs an experimental drug’s muddled data and a desperate need

Health Lizzy Lawrence

STAT Plus: Tuberculosis outbreak tied to bone grafts underscores shortcomings of testing

Biotech Erica Goode

STAT Plus: Failed clinical trials don’t always spell doom for a new drug. Here’s why

Politics John Wilkerson

STAT Plus: More regulation could be coming for drug ads

Biotech Brittany Trang

STAT Plus: FDA approves Sage Therapeutics’ rapid-acting medication for postpartum depression but not major depression

Pharmalot Ed Silverman

STAT Plus: Intas Pharma employee used acid to destroy manufacturing records at troubled plant

Politics Adam Feuerstein and Matthew Herper

Vivek Ramaswamy wants to ‘gut’ the FDA. His claims don’t hold up to scrutiny

Biotech Jason Mast

STAT Plus: Gene therapy is in crisis. For nine hours, the field’s leading minds looked for a solution

Pharmalot Ed Silverman

STAT Plus: FDA inspection underscores problem at major U.S. compounder behind hospital drug recalls

Pharmalot Ed Silverman

STAT Plus: Pfizer says most tornado damage at key plant hit warehouse, but finished drugs also impacted